6. CAR-T Therapy For Leukaemia
Chimeric Antigen Receptor-T cell (or CAR-T) is a form of cellular immunotherapy and this means ground breaking change for leukaemia patients. The therapy involves removing a patient’s T-cells and genetically modifying them to seek and destroy cancer cells. Once the T-cells have killed foreign cancer cells, they remain in the body to prevent the risk of a relapse.
This unique treatment could spell an end to chemotherapy in future and is expected to tackle even advanced stage leukaemia. To that end, official treatment for a case of acute lymphoblastic leukaemia is to be presented at the U.S. Food and Drug Administration next year.
Discussion about this post